14 articles for A Kinoshita
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
18
Discovery of Novel Seven-Membered Prostacyclin Analogues as Potent and Selective Prostaglandin FP and EP3 Dual Agonists.

Ono Pharmaceutical
24
Discovery of G Protein-Biased EP2 Receptor Agonists.

Ono Pharmaceutical
21
Structural optimization and structure-functional selectivity relationship studies of G protein-biased EP2 receptor agonists.

Ono Pharmaceutical
12
Discovery of highly potent dual EP(2) and EP(3) agonists with subtype selectivity.

Ono Pharmaceutical
39
Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma.

Setsunan University
18
Discovery of long-acting N-(cyanomethyl)-N-alkyl-L-prolinamide inhibitors of dipeptidyl peptidase IV.

Minase Research Institute
21
Design and synthesis of DPP-IV inhibitors lacking the electrophilic nitrile group.

Ono Pharmaceutical
31
Discovery of new orally active prostaglandin D2 receptor antagonists.

Ono Pharmaceutical
23
3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. Part 3: Synthesis, metabolic stability, and biological evaluation of optically active analogs.

Minase Research Institute
23
Discovery of novel N-acylsulfonamide analogs as potent and selective EP3 receptor antagonists.

Minase Research Institute
51
3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. part 2: optimization of the side chains to improve in vitro and in vivo potencies.

Minase Research Institute
30
Design and synthesis of new potent dipeptidyl peptidase IV inhibitors with enhanced ex vivo duration.

Minase Research Institute
51
Substituted 3-(phenylsulfonyl)-1-phenylimidazolidine-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase.

Suntory
13
Synthesis and evaluation of a potent, well-balanced EP

Ono Pharmaceutical